ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

Links shared publicly online about this topic.

380
total visits

ViroXis' IND for EISO-derived product to treat HPV skin warts receives FDA approval

ViroXis Corporation today announced that the US Food and Drug Administration (FDA) granted approval for the Company's investigational new drug (IND) application and planned clinical development of a drug substance derived from East Indian Sandalwood oil (EISO) for the topical treatment of Human Papilloma Virus (HPV), common warts of the skin.

View full resource at news-medical.net

Tags: Skin, Wart, STD, HPV, Diet and Nutrition, Drug, FDA